ENTITY
Resapp Health

Resapp Health (RAP AU)

20
Analysis
Health CareAustralia
ResApp Health Limited focuses on developing respiratory disease diagnosis and management mobile phone application technology. The Company offers respiratory diagnosis applications for mobile phones. ResApp Health serves customers in Australia.
more
Refresh
bearishResapp Health
04 Aug 2022 15:18

ResApp’s Revised Offer from Pfizer Still Faces Headcount Test Risk

The risk/reward profile is unfavourable as ResApp is a highly-held retail stock, posing a headcount test risk to the scheme. At the last close, the...

Logo
292 Views
Share
bullishResapp Health
03 Aug 2022 11:46

ResApp (RAP AU): Pfizer Bumps Offer

At A$0.182/share as I type, ResApp is trading at a wide 15.5% gross spread. The price matches the IE's preferred value. Get involved here. The...

Logo
374 Views
Share
x